Selinexor
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Arms / Cohorts
Experimental Arm:Carfilzomib-containing Regimen
Accepting patients
Experimental Arm:Pomalidomide-containing Regimen
Accepting patients
Experimental Arm:Daratumumab-containing Regimen
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.